Join us on Thursday, May 26 in Cambridge, United Kingdom
4:30 p.m. - 8:00 p.m. BST
When it comes to the commercialization of biologics, effective cell line development (CLD) is essential for success, but there is no one right way to tackle it.
This event will highlight the advantages and disadvantages of various approaches to CLD and the impact early decision-making can have at later stages of biologics development. Industry leaders from Abzena, AstraZeneca, GSK will share their experiences and discuss the best practices in developing robust, stable, high-yielding cell lines to accelerate and streamline drug discovery.
Our cocktail hour will offer the opportunity to network with fellow start-ups and industry leaders. You can also book 1-on-1 consulting sessions with Sartorius experts.
Meet our Sartorius experts at this free event for early stage biotech start-ups developing biologics or for anyone looking for cell line development solutions to ease their journey to commercialization.
Event Highlights
CHO Me the Way | Fundamentals of Cell Line Development
Efficiently navigating the challenges of cell line development process can have a significant impact on later stages of biologics development. Dr Yash Patel, our cell line development specialist, will discuss:
- Key steps and challenges to consider during CLD
- Benefits and drawbacks of developing cell lines in-house versus out-sourcing
- Tools to maximize efficiency and reduce risks during CLD
Ready Steady CHO | Panel Discussion
Industry experts from leading biologics companies will share their experiences and common practices in CLD. The panel discussion will provide insights into:
- Challenges when developing cell lines in-house and how to avoid them
- Best practices and technologies to streamline CLD
- Points to consider when choosing a service provider for CLD
Treat CHOself | Cocktail Hour and Networking
Join us for a drink and connect with fellow innovators and industry experts. You can also schedule a 1-on-1 meeting with Sartorius experts to get more insights into CLD and beyond
- Modern cell line development workflows and their critical steps.
- Various approaches to CLD and their advantages and disadvantages.
- Key points to consider when evaluating external providers of CLD products and services.
If you have any further questions, please do not hesitate to contact us. We would be pleased to help you.
Ieva Salkauskaite
Sartorius Stedim UK Limited
Meet our Sartorius experts at this free event for early stage biotech start-ups developing biologics or for anyone looking for cell line development solutions to ease their journey to commercialization.
A Perfect Fit, From Start to Finish
With a flexible portfolio for cell line development (CLD) solutions and beyond, Sartorius addresses your needs at every stage of the journey to commercialization, whether you need a fully outsourced solution or select product and services to complement your in-house CLD capabilities.
Cell Line Development Instruments
Making the right decisions early is a key differentiator in cell line development. Increase lab productivity and reduce costs by enhancing your selection and characterization processes through high-throughput solutions.
CLD Services
A misstep during early-stage drug development can cause major delays to commercialization. Increase your chances of success by choosing a competent and experienced partner for your cell line development project.
CLD Custom Solutions
Tailor your unique approach to CLD with flexible solutions that enhance and extend your capabilities. Sartorius’ full range of products and services so that you can get the right technologies and expertise at the right time.
